Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel R. Bergman"'
Autor:
Daniel R. Bergman, Yixuan Wang, Erica Trujillo, Anthony A. Fernald, Lie Li, Alexander T. Pearson, Randy F. Sweis, Trachette L. Jackson
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Bladder cancer is an increasingly prevalent global disease that continues to cause morbidity and mortality despite recent advances in treatment. Immune checkpoint inhibitors (ICI) and fibroblast growth factor receptor (FGFR)-targeted therapeutics hav
Externí odkaz:
https://doaj.org/article/47f612fceba0467fa1c634ad054c7f8d
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Bergman, Karikomi et al. propose a multiscale evolutionary model to describe tumor-immune-EMT interactions and their impact on epithelial cancer progression, which highlights a controllable region that maximizes invasion-free survival. Using EMT-infl
Externí odkaz:
https://doaj.org/article/f69f8c00bcdf4bb0ab8fdb4757e03707
The advent of immune checkpoint therapy for metastatic skin cancer has greatly improved patient survival. However, most skin cancer patients are refractory to checkpoint therapy, and furthermore the differential intra-immune signaling between cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d3daa50ed4607c4eb4d481e73330c9f
https://doi.org/10.1101/2020.09.15.298182
https://doi.org/10.1101/2020.09.15.298182
During progression from carcinoma in situ to an invasive tumor, the immune system is engaged in complex sets of interactions with various tumor cells. Tumor cell plasticity also alters disease trajectories via epithelial-to-mesenchymal transition (EM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad7ef36bcd51a8804ae389793bcb95c1
https://doi.org/10.1101/615971
https://doi.org/10.1101/615971
Autor:
Yixuan Wang, Daniel R Bergman, Erica Trujillo, Alexander T. Pearson, Randy F. Sweis, Trachette L. Jackson
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Immunotherapy has dramatically transformed the cancer treatment landscape largely due to the efficacy of immune checkpoint inhibitors (ICIs). Although ICIs have shown promising results for many patients, the low response rates in many cancer
Externí odkaz:
https://doaj.org/article/af4e1bfaea004d1cbbe01ea74fa6cf31